Pharmacological targeting of the serotonergic system for the treatment of obesity

Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization

(2008) W. J. Thomsen et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Serotonin 5-HT2CReceptor Agonist Promotes Hypophagia via Downstream Activation of Melanocortin 4 Receptors

(2007) Daniel D. Lam et al.   ENDOCRINOLOGY

The development of tolerance to drugs that suppress food intake

(2007) John D. Fernstrom et al.   PHARMACOLOGY & THERAPEUTICS

Selective 5-HT6 receptor ligands: Progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders

(2007) D.J. Heal et al.   PHARMACOLOGY & THERAPEUTICS

Sucrose intake and fasting glucose levels in 5-HT1A and 5-HT1B receptor mutant mice

(2007) Anita J. Bechtholt et al.   PHYSIOLOGY & BEHAVIOR

Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats

(2006) Angels Fisas et al.   BRITISH JOURNAL OF PHARMACOLOGY